Aurobindo Pharma Limited has released its Business Responsibility and Sustainability Report for the financial year ending March 31, 2024. The report highlights the company’s ongoing efforts to align with global sustainability standards and its commitment to responsible business practices. This comprehensive report covers various aspects of the company’s operations, including environmental responsibility, economic performance, social responsibility, and ethical conduct.
Aurobindo Pharma’s approach to sustainability is multi-faceted, emphasizing energy conservation, water management, waste reduction, and greenhouse gas (GHG) emission controls. The company has made significant strides in reducing its environmental footprint, underscoring its commitment to sustainable development.
Environmental Responsibility
A major focus of the report is Aurobindo Pharma’s energy consumption and conservation initiatives. The company has implemented numerous projects aimed at reducing CO2 emissions, resulting in a reduction of approximately 237,455 tons of CO2 equivalent. Renewable energy sources now constitute a significant percentage of the company’s total energy consumption.
Water management is another critical area where Aurobindo Pharma has made progress. The report details the company’s total water consumption and water intensity metrics, showcasing efforts to optimize water use and reduce waste.
Waste management practices at Aurobindo Pharma are robust, with a comprehensive approach to reducing, recycling, and properly disposing of waste. In the fiscal year 2024, the company generated 56,212 metric tons of waste, including plastic, e-waste, biomedical waste, hazardous waste, and fly ash. Notably, 836 tons of plastic waste and 30,741 tons of fly ash were recovered through recycling processes.
GHG emissions are meticulously tracked, with the report providing detailed figures for Scope 1 and Scope 2 emissions. The total emissions per million rupees of turnover stood at 3.34 metric tons. The company has undertaken various projects to reduce these emissions, including solar power generation, biomass fuel usage, and the utilization of piped natural gas.
Air quality improvements are also highlighted, with reductions in NOx, SOx, and particulate matter emissions compared to previous years.
Social Responsibility
Aurobindo Pharma’s commitment to social responsibility is evident in its employee well-being programs, community engagement initiatives, and customer relations. The company promotes workforce diversity and inclusion, ensuring a healthy and safe working environment for its employees. Community development programs focus on health, education, and environmental sustainability, reflecting the company’s dedication to making a positive impact on society.
Customer satisfaction and quality management remain high priorities for Aurobindo Pharma, ensuring that the company’s products and services meet the highest standards.
Ethical Conduct
Ethical conduct is a cornerstone of Aurobindo Pharma’s operations. The report outlines the company’s anti-corruption measures and adherence to legal and regulatory requirements. By maintaining high ethical standards, Aurobindo Pharma continues to build trust with stakeholders and uphold its reputation as a responsible corporate citizen.
Conclusion
Aurobindo Pharma’s Business Responsibility and Sustainability Report for FY 2024 provides a comprehensive overview of the company’s efforts to integrate sustainability into its operations. By focusing on energy and water management, waste reduction, GHG emission controls, and social responsibility, Aurobindo Pharma demonstrates its commitment to sustainable development. The report underscores the company’s ongoing dedication to balancing economic growth with environmental stewardship and social responsibility.
Source: BRSR
Credit: Aurobindo Pharma Limited